Imitrex, Sumatriptan Wire
Comprehensive News Feed for Imitrex, Sumatriptan (generic).
Results 1 - 20 of 131 in Imitrex, Sumatriptan (generic)
-
Suppression of Clinical Trials of Sumatriptan
Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsor's product were suppressed. Comment?
-
Is Dr. Reddy's Laboratories Ready to Run?
While I've traded Dr. Reddy's Laboratories in the past, I have not touched it in the past few years; however as we await for the new Market Vectors Indian Small Cap fund to launch, I was poking my nose around Indian stocks this weekend since the Indian market has corrected quite a bit . Comment?
-
Dr Reddy's seeks US marketing rights for `Lipitor' generic
Integrated pharmaceuticals company Dr Reddy's Laboratories has filed for marketing rights to a generic version of Pfizer's cholesterol-lowering drug Lipitor, in the US, reports quoting company sources said. Comment?
-
New product launches, limited competition helped boost Par's Q3
WOODCLIFF LAKE, N.J. Generic drug maker Par Pharmaceutical had revenues of $294.8 million and profits of $26.3 million during third quarter 2009, the company announced in a financial report Friday. Comment?
-
At the onset of a migraine, the pain can be absolutely debilitating. Experiencing one can leave the senses vulnerable to light, to sound, to touch. Comment?
-
What do you BFing mommies take for migraines?
Last night, I had the mother of all migraines. It was horrible. I haven't had one that bad in years. Comment?
-
Pozen Inc. Reports Operating Results
Pozen Inc. filed Quarterly Report for the period ended 2009-09-30. Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Comment?
-
Is there a Sure Fire Drug out there that stops migraines?
Is there a Sure Fire Drug out there that stops migraines? 10/30/09 sara Topics: Migraine Treatment I have suffered from migraines since I was 13. Comment?
-
Popular medicine in new form could get around nausea problem for migraine sufferers
PHILADELPHIA, PA.; October 29, 2009 -- The 30 million Americans who get migraines know they are more than just headaches. Comment?
-
Zogenix, Desitin Pharmaceuticals announce filing for European regulatory approval of SUMAVEL DosePro
The announcement follows successful completion of a European pivotal bioequivalence trial comparing needle-free SUMAVEL DosePro to a traditional needle-based autoinjector, Imigran-Inject, the European brand of Imitrex STATdose System. Comment?
-
Glaxo profit rose as currency gains o0ffset generics
Net income increased to 1.34 billion pounds from 1.03 billion pounds a year earlier, London-based Glaxo said in a Regulatory News Service statement today. Comment?
-
Zogenix and Desitin Announce Filing for European Regulatory Approval...
Zogenix, Inc., a privately held pharmaceutical company, and Desitin Pharmaceuticals GmbH , a privately held, mid-sized German pharmaceutical company, today announced that Desitin has filed for European regulatory approval of SUMAVEL DosePro needle-free delivery system. Comment?
-
Third-quarter fiscal 2009 results announced by POZEN
POZEN Inc. , today announced results for the third quarter ended September 30, 2009. Comment?
-
POZEN Reports Third Quarter 2009 Results
POZEN Inc. , today announced results for the third quarter ended September 30, 2009. Comment?
-
Headache and fatigue in a teenager
You are the resident on call in the pediatric emergency department when you observe a father carrying in his teenage son. Comment?
-
Author of "Living Well with Migraine Disease and Headaches" Patient advocate and writer Teri Robert's career moved in this... Saturday, October 24, 2009 Teri Robert Lisa, One of the effects of the ergotamine medications -- DHE and Migranal Nasal Spray -- and the triptans -- Imitrex, Maxalt, Zomg, etc. Comment?
-
Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Ltd more than doubled its net profit to Rs 217 crore during the July-September quarter compared to Rs 105 crore in the same period last year, its consolidated results announced today show. Comment?
-
Dr Reddy's July-September net zooms 106 per cent to Rs217 crore
Dr Reddy's Laboratories Ltd today reported a 106 per cent jump in its after-tax profit at Rs217.3 crore for fiscal second quarter . Comment?
-
Zogenix And Astellas Announce Data Published Showing The Benefits Of...
Main Category: Headache / Migraine Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 23 Oct 2009 - 3:00 PDT Zogenix, Inc. Comment?
-
Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the second quarter ended September 30, 2009 under International Financial Reporting Standards . Comment?
Imitrex, Sumatriptan Forum
Most Popular
- Get ready, America: Here comes Sarah Palin - 292 comments
- Ethiopia Discovers Mine With Gold Inside Worth 1.7 Billion - 262 comments
- Arkansas 10-Year-Old Won't Pledge Allegiance Until Gays Gain Equality. - 236 comments
- Palin: McCain aides kept me 'bottled up' - 172 comments
- Economy to top Obama agenda in Asia - 109 comments
- Accused Sept. 11 mastermind to be tried in NY - 78 comments
- 5 types of men women hate - 94 comments
- Napolitano pronounces US border more secure now - 63 comments
- Sarah Palin to Visit Fort Hood - 102 comments
- Pat Robertson on Ft. Hood: Islam is 'not a religion' and... - 63 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
